Carl E. Orringer

17.4k citations
55 papers · 3.7k indexed · 8 hit papers · h-index 24
Topics
Lipoproteins and Cardiovascular Health (37 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers)Health Systems, Economic Evaluations, Quality of Life (14 papers)

In The Last Decade

Carl E. Orringer

52 papers receiving 3.6k citations

Hit Papers

National Lipid Association Recommendations for Patient-Ce...201420262018202220152014201620192022100200300400500

Peers

Carl E. Orringer
Comparison fields: 5 of 119
  • Surgery 2.4k
  • Endocrinology, Diabetes and Metabolism 1.2k
  • Cardiology and Cardiovascular Medicine 1.0k
  • Economics and Econometrics 787
  • Cancer Research 415
Replace Margaret J. Thomason with:
Margaret J. Thomason United Kingdom
C Pollicino Australia
Dorothea Collins United States
Evan A. Stein United States
Rafael Carmena Spain
Gabriele Riccardi Italy
Danielle M. Brennan United States
Matthew K. Ito United States
R Peto United Kingdom
Shona Livingstone United Kingdom
Carl E. Orringer relative to Margaret J. Thomason United Kingdom Margaret J. Thomason's profile →
Citations per field
00.5×7.6×
Margaret J. Thomason · 1×
Citations per year

Countries citing papers authored by Carl E. Orringer

Since Specialization
Citations

This map shows the geographic impact of Carl E. Orringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl E. Orringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl E. Orringer more than expected).

Fields of papers citing papers by Carl E. Orringer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl E. Orringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl E. Orringer. The network helps show where Carl E. Orringer may publish in the future.

Co-authorship network of co-authors of Carl E. Orringer

This figure shows the co-authorship network connecting the top 25 collaborators of Carl E. Orringer. A scholar is included among the top collaborators of Carl E. Orringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl E. Orringer. Carl E. Orringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 4
4
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Riskbreakdown →
290
5 4
6
Managing Atherosclerotic Cardiovascular Risk in Young Adultsbreakdown →
118
7 40
8 2
9 7
10 124
11 0
12
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Associationbreakdown →
339
13 1
14
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Riskbreakdown →
280
15 80
16
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Riskbreakdown →
355
17 15
18
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summarybreakdown →
364
19 1
20 45

About Carl E. Orringer

Carl E. Orringer is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Health Informatics, having authored 55 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (37 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Surgery (2.4k citations) and Cardiology and Cardiovascular Medicine (1.0k citations). Carl E. Orringer has collaborated with scholars based in United States, Türkiye and Italy. Frequent co-authors include Terry A. Jacobson, Kevin C. Maki, Don P. Wilson, Pamela B. Morris, Christie M. Ballantyne, Kim K. Birtcher, Harold Bays, Donald M. Lloyd‐Jones, W. Virgil Brown and Sondra M. DePalma. Their work appears in journals such as New England Journal of Medicine, Journal of the American College of Cardiology and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026